Melissa Millard

2.3k total citations
18 papers, 1.9k citations indexed

About

Melissa Millard is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Melissa Millard has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Melissa Millard's work include Cancer Research and Treatments (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Melissa Millard is often cited by papers focused on Cancer Research and Treatments (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Melissa Millard collaborates with scholars based in United States, Sweden and Italy. Melissa Millard's co-authors include Nouri Neamati, Ronald A. DePinho, K. Lenhard Rudolph, Divya Pathania, Marcus Bosenberg, Srinivas Odde, Sandy Chang, Nicole Schreiber‐Agus, Bogdan Olenyuk and John D. Gallagher and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Melissa Millard

17 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Millard United States 14 1.1k 504 298 228 172 18 1.9k
Matthew J. Taylor United States 21 646 0.6× 148 0.3× 237 0.8× 375 1.6× 206 1.2× 33 1.8k
Vanessa C. Gray‐Schopfer United Kingdom 7 1.3k 1.1× 158 0.3× 733 2.5× 195 0.9× 118 0.7× 8 1.9k
Joan Chang United Kingdom 20 683 0.6× 102 0.2× 329 1.1× 222 1.0× 119 0.7× 33 1.5k
Prakash Radhakrishnan United States 21 986 0.9× 173 0.3× 549 1.8× 429 1.9× 187 1.1× 47 1.7k
Oliver Plettenburg Germany 23 750 0.7× 166 0.3× 139 0.5× 135 0.6× 386 2.2× 63 1.6k
David B. Darr United States 25 1.4k 1.3× 257 0.5× 937 3.1× 426 1.9× 127 0.7× 49 2.7k
Christine Pirker Austria 31 1.4k 1.3× 152 0.3× 1.0k 3.5× 448 2.0× 423 2.5× 92 3.0k
Keiko Kawauchi Japan 21 1.2k 1.1× 99 0.2× 451 1.5× 557 2.4× 67 0.4× 63 1.9k
Martin K. Bijsterbosch Netherlands 25 1.0k 0.9× 119 0.2× 225 0.8× 255 1.1× 139 0.8× 46 1.9k
Keiichiro Okuhira Japan 26 1.7k 1.5× 146 0.3× 817 2.7× 248 1.1× 79 0.5× 62 2.4k

Countries citing papers authored by Melissa Millard

Since Specialization
Citations

This map shows the geographic impact of Melissa Millard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Millard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Millard more than expected).

Fields of papers citing papers by Melissa Millard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Millard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Millard. The network helps show where Melissa Millard may publish in the future.

Co-authorship network of co-authors of Melissa Millard

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Millard. A scholar is included among the top collaborators of Melissa Millard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Millard. Melissa Millard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lattanzio, Rossano, Gianluca Sala, Melissa Millard, et al.. (2023). The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS Letters. 598(2). 252–265. 6 indexed citations
2.
Millard, Melissa, et al.. (2023). Abstract 202: Perfused patient-derived tumor organoid models with autologous immune cells for preclinical drug development. Cancer Research. 83(7_Supplement). 202–202.
3.
Millard, Melissa, Natalie Williams, Ashley Elrod, & Teresa M. DesRochers. (2022). Abstract 3086: Organoids standardized to a clinically validated drug response assay for truly predictive in vitro drug response profiling. Cancer Research. 82(12_Supplement). 3086–3086. 1 indexed citations
4.
Smith, Ashley M., Melissa Millard, Lillia Holmes, et al.. (2018). Abstract 1121: Profiling patient-specific glioblastoma drug response in vitro using complex 3D microtumors. Cancer Research. 78(13_Supplement). 1121–1121. 1 indexed citations
5.
Erdreich‐Epstein, Anat, Alok R. Singh, Shweta Joshi, et al.. (2016). Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 8(32). 52193–52210. 24 indexed citations
6.
Millard, Melissa, et al.. (2013). Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells. PLoS ONE. 8(1). e54346–e54346. 16 indexed citations
7.
Ji, Yanbin, Subhabrata Majumder, Melissa Millard, et al.. (2013). In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide. Journal of the American Chemical Society. 135(31). 11623–11633. 199 indexed citations
8.
Millard, Melissa, John D. Gallagher, Bogdan Olenyuk, & Nouri Neamati. (2013). A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers. Journal of Medicinal Chemistry. 56(22). 9170–9179. 142 indexed citations
9.
Millard, Melissa, Divya Pathania, Fedora Grande, Shili Xu, & Nouri Neamati. (2011). Small-Molecule Inhibitors of p53-MDM2 Interaction: the 2006-2010 Update. Current Pharmaceutical Design. 17(6). 536–559. 54 indexed citations
10.
Millard, Melissa, Srinivas Odde, & Nouri Neamati. (2011). Integrin Targeted Therapeutics. Theranostics. 1. 154–188. 208 indexed citations
11.
Yamada, Roppei, Xuefei Cao, Alexey N. Butkevich, et al.. (2011). Discovery and Preclinical Evaluation of a Novel Class of Cytotoxic Propynoic Acid Carbamoyl Methyl Amides (PACMAs). Journal of Medicinal Chemistry. 54(8). 2902–2914. 25 indexed citations
12.
Millard, Melissa, et al.. (2010). Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity. PLoS ONE. 5(10). e13131–e13131. 108 indexed citations
13.
Xu, Jingying, Melissa Millard, Xiuhai Ren, Órla T. Cox, & Anat Erdreich‐Epstein. (2010). c-Abl mediates endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 and by disruption of actin. Blood. 115(13). 2709–2718. 26 indexed citations
14.
Pathania, Divya, Melissa Millard, & Nouri Neamati. (2009). Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆. Advanced Drug Delivery Reviews. 61(14). 1250–1275. 233 indexed citations
15.
Erdreich‐Epstein, Anat, Linda Tran, Órla T. Cox, et al.. (2005). Endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 involves ceramide metabolic pathways. Blood. 105(11). 4353–4361. 56 indexed citations
16.
Erdreich‐Epstein, Anat, Linda Tran, Hongtao Wang, et al.. (2002). Ceramide Signaling in Fenretinide-induced Endothelial Cell Apoptosis. Journal of Biological Chemistry. 277(51). 49531–49537. 72 indexed citations
17.
Rudolph, K. Lenhard, Melissa Millard, Marcus Bosenberg, & Ronald A. DePinho. (2001). Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genetics. 28(2). 155–159. 425 indexed citations
18.
Rudolph, K. Lenhard, Sandy Chang, Melissa Millard, Nicole Schreiber‐Agus, & Ronald A. DePinho. (2000). Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery. Science. 287(5456). 1253–1258. 318 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew J. Taylor Breakdown of academic impact, for papers by Vanessa C. Gray‐Schopfer Breakdown of academic impact, for papers by Joan Chang Breakdown of academic impact, for papers by Prakash Radhakrishnan Breakdown of academic impact, for papers by Oliver Plettenburg Breakdown of academic impact, for papers by David B. Darr Breakdown of academic impact, for papers by Christine Pirker Breakdown of academic impact, for papers by Keiko Kawauchi Breakdown of academic impact, for papers by Martin K. Bijsterbosch Breakdown of academic impact, for papers by Keiichiro Okuhira
Rankless by CCL
2026